<DOC>
	<DOCNO>NCT01771185</DOCNO>
	<brief_summary>Gastric bypass surgery resolve type 2 diabetes mellitus ( T2DM ) without need diabetes therapy ~80 % patient . Moreover , improvement insulin sensitivity glucose homeostasis occurs within day surgery significant weight loss achieve . This observation lead notion bypass upper gastrointestinal ( GI ) tract specific therapeutic effect insulin action glucose metabolism . In fact , surgical endoscopic procedure bypass upper GI tract currently study human subject . Recently , new surgical technique , duodenal-jejunal bypass surgery ( DJBS ) , develop specifically treat T2DM . Data preliminary study show DJBS result glycemic control 87 % overweight obese patient T2DM.These subject undergo metabolic study University Hospital Sao Paulo surgical procedure . Washington University investigator : 1 ) provide technical support guidance physician perform study Brazil , 2 ) process analyze blood sample obtain study Washington University Center Human Nutrition , 3 ) involve analyze data write final manuscript . The effect DJBS follow clinical metabolic parameter evaluate</brief_summary>
	<brief_title>Metabolic Effects Gastrointestinal Surgery T2DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>Uncontrolled diabetes ( A1c &gt; 8 % ) Less 10 year history Not take insulin Ages 20 65 year old BMI 2634 previous abdominal surgery LADA Using insulin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>metabolic surgery</keyword>
	<keyword>insulin resistance</keyword>
</DOC>